Image (B9878674 E349 4222 8dee B026f4f0c5b9 01)
Ranitidine
Product Images NDC 71821-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 71821-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vkt Pharma Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
150 mg (B9878674 E349 4222 8dee B026f4f0c5b9 02)
This is a description for a medication called Ranitidine, in the form of Tablets. The typical dosage and administration information can be found on the packaging. The tablets are manufactured by VKT Pharma Private Limited in India. The medication contains 168mg of Ranitidine hydrochloride, USP equivalent to 150mg of Ranitidine. The packaging includes safety information about replacing the cap securely. A pattern varnish appears on the packaging, along with the NDC code. The text mentions a "non-varnish area" that is 16mm by 50.8mm, as well as a "restricted area" for encoding. The number 138.125mm is also present, but its significance is unclear.*
300 mg (B9878674 E349 4222 8dee B026f4f0c5b9 03)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
